Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension. [electronic resource]
Producer: 20200413ISSN:- 1422-0067
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- analogs & derivatives
- Animals
- Cyclic Nucleotide Phosphodiesterases, Type 5 -- genetics
- Drug Delivery Systems -- methods
- Humans
- Imatinib Mesylate -- therapeutic use
- Nanoparticles -- chemistry
- Pulmonary Arterial Hypertension -- drug therapy
- Quinolines -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.